Drug intelligence / Profile preview

Prefera

Development stage: Unknown
Lead developer: Meda
Modality: Small Molecules
Administration: Oral

Overview

Prefera is a brand name for a multivitamin, mineral, and fatty acid product primarily used as a prenatal vitamin. It is designed to treat or prevent vitamin deficiency before, during, and after pregnancy, supporting both maternal health and fetal development. Key ingredients typically include iron, folic acid, and sometimes docosahexaenoic acid (DHA), which are essential nutrients for various physiological processes.

Brand names: PreferaPrefera-OB OnePrefera OB Plus DHAPrefera OB Tablet

Beyond the preview

Go deeper on Prefera.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prefera.

Explore the full profile